Enterin Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Enterin

Access the complete profile.

Enterin Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address	2005 Market St Ste 3125 Philadelphia, PA 19103

Note: Revenues for privately held companies are statistical evaluations.


Enterin's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Enterin's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Enterin is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Enterin Annual Revenue and Growth Rate

Enterin	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Enterin's revenues are gauged from an analysis of company filings.

Enterin's Income Statement (based on Industry Averages)

Enterin P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Enterin has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 6, 2023	4	25%	$20 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Enterin is developing and marketing. Enterin doesn't have any recent trademark applications, indicating Enterin is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KENTERIN Pharmaceutical preparations for use in the treatment of viral infections, endocrine disorders, gastrointestinal disorders and neurological disorders	12/20/2019

See all trademarks and details in the Full Report.

Market Share of Enterin's Largest Competitors

A competitive analysis shows these companies are in the same general field as Enterin, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Enterin. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GLOBAL AFFILIATES	Philadelphia, PA	100
E.K. LAY	Philadelphia, PA	40
ENTERIN	Philadelphia, PA	26
BHS PHARMACY INC. T/A NORTH PHILLY PHARMACY	Philadelphia, PA	18
TIMI PHARMACEUTICALS	Philadelphia, PA	18
KEYSTONE PHARMACY PURCHASING ALLIANCE	Philadelphia, PA	13

Future Competition: Enterin's Fastest Growing Competitors

These companies are in the same general field as Enterin and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)